Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
02/2010
02/09/2010US7659314 PH-sensitive polymeric micelles for drug delivery
02/09/2010CA2413061C Serine protease inhibitors
02/09/2010CA2192092C Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors
02/04/2010WO2010012949A1 Marker reagents with a pyridine ring with a diazomethyl function substituent methods for synthesis of said reagents and methods for detecting biological molecules
02/04/2010WO2010012442A2 Insecticidal benzenedicarboxamide derivative
02/04/2010CA2730711A1 Asymmetric process for making substituted 2-amino-thiazolones
02/03/2010EP2149550A1 Nitrogen-containing five-membered heterocyclic compound
02/03/2010CN101641335A Amino-5-[substituted-4-(difluoromethoxy)phenyl]-5- phenylimidazolone compounds as ss-secretase inhibitors
02/03/2010CN100586935C 1-imidazolylmethyl-substituted-2-naphtols and their use as accelerators for low-temperature curing
02/02/2010US7655820 Method for producing molecular compound
02/02/2010US7655804 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
02/02/2010US7655803 [1,3-Dimethylimidazolium][Me-(O CH2 CH2)2 O SO3]; Trioctylmethylammonium][Me-(O CH2 CH2)2 O SO3]; 1-Methylpyridinium][Me-(O CH2 CH2)5 O SO3]; treating the compound of formula (cation)(R O SO3) with an alcohol of the formula R' OH to form the desired ionic liquid and the by-product R OH
02/02/2010US7655684 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease
02/02/2010CA2358581C Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them
02/02/2010CA2349903C Ionic liquids ii
02/02/2010CA2294809C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same
01/2010
01/28/2010WO2010011821A2 Dual-acting antihypertensive agents
01/28/2010WO2010009990A1 Process for preparing 1,3-disubstituted pyrazolecarboxylic esters
01/28/2010WO2010009508A1 Antiparasitic compounds
01/28/2010US20100022781 Trypsin-like serine protease inhibitors, and their preparation and use
01/28/2010US20100022773 Apoptosis promoters
01/28/2010US20100022744 Clathrate compound, curing catalyst, composition for forming cured resin, and cured resin
01/28/2010US20100022594 thiophene sulfonamide derivatives such as 5-Chloro-N-[(S)-2-hydroxy-1-phenylethyl]thiophene-2-sulfonamide, that inhibit the production of beta amyloid protein from amyloid precursor protein; capable of passing through the blood-brain barrier, used for treatment of Alzheimer's disease and Down's syndrome
01/28/2010US20100022542 Compounds exhibiting thrombopoietin receptor agonism
01/28/2010US20100022394 Products for the treatment of the iron chlorosis
01/28/2010US20100021833 Dithiolene metal complex colorless ir absorbers
01/27/2010EP2146968A1 Urea derivatives as glutaminyl cyclase inhibitors
01/27/2010EP2146963A2 Dual-acting antihypertensive agents
01/27/2010CN101633643A Ornidazole compound in new path
01/27/2010CN101633642A Preparation method of N-alkyl imidazole
01/27/2010CN101633641A Preparation method of imidazole type ionic liquid
01/26/2010US7652143 2-(3-(4-benzyloxybenzyl)-2-oxoimidazolidin-1-yl)-N-hydroxy-3-methylbutyramide; N-hydroxy-3-methyl-2-{2-oxo-3-(4-(pyridin-4-ylmethoxy)benzyl)imidazolidin-1-yl}butyramide with trifluoroacetic acid ; osteoarthrosis and rheumatoid arthritis; TNF- alpha converting enzyme (TACE) inhibitor
01/26/2010US7652056 Using 4-imidazoline carboxylic acid or ester; antiinflammatory agents; microbiocides; bactericides; antitumor agenst0
01/26/2010US7652055 2-imidazolines
01/26/2010US7652054 Gastrointestinal disorders; cardiovascular disorders; dyspepsia;anticancer agents; antiulcer agents
01/26/2010US7652045 Activator of peroxisome proliferator-activated receptor δ
01/26/2010US7652033 HIF-1 inhibitors
01/26/2010CA2338854C Nitric esters and nitrate salts of specific drugs
01/26/2010CA2299470C Eprosartan arginyl charge-neutralization-complex and a process for its production and formulation
01/21/2010WO2010009402A2 Nilotinib intermediates and preparation thereof
01/21/2010WO2010009062A1 Imidazole carboxamides
01/21/2010WO2010008522A2 Nucleophilic fluorination of aromatic compounds
01/21/2010WO2010008213A2 Silane based compound, method for preparing the same, and surface treating agent composition for copper foil including the silane based compound
01/21/2010WO2010007318A2 Novel imidazo[1,2-a]pyrimidine derivatives, method for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use in particular as met inhibitors
01/21/2010WO2010006792A1 Synthesis of cyclic amidines
01/21/2010WO2009130735A4 Fatty acid derivatives for oral administration endowed with high paia- tability
01/21/2010WO2009115927A3 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use
01/21/2010WO2008156092A8 Azolylmethylidenehydrazine derivative and use thereof
01/21/2010WO2008128045A8 Solid forms of (e) -1- (4- ( (1r, 2s, 3r) -1, 2, 3, 4-tetrahydroxybutyl) -1h-imidazol-2-yl)ethanone oxime
01/21/2010US20100016597 Method for producing pulverized organic compound particle
01/21/2010US20100016590 Nilotinib intermediates and preparation thereof
01/21/2010US20100016475 Imidazole salts, method for producing them, use thereof and epoxy resins containing said salts
01/21/2010US20100016380 TNF-alpha production inhibitors
01/21/2010US20100016373 such as 1-methyl-1H-imidazole-4-carboxylic acid 4-(3-hydroxy-4-isobutyryl-2-trifluoromethyl-phenoxymethyl)-benzylamide; preferential modulatators of glutamate receptors, used as antidepressants and anxiolytic agents
01/21/2010US20100016259 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators
01/21/2010CA2731215A1 Imidazole carboxamide derivatives and their use in treatment of conditions associated with the mglur2 receptor
01/21/2010CA2730964A1 Imidazo [1, 2-a] pyrimidine derivatives method for the production thereof application thereof as medicaments pharmaceutical compositions and use thereof as met inhibitors
01/20/2010EP2144885A1 Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors
01/20/2010EP2144884A2 Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds for the inhibition of beta-secretase
01/20/2010EP2144883A1 Crystalline forms i and ii of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1h-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine
01/20/2010EP2144882A2 Tris(heterocyclyl) metal complexes as bleach catalysts
01/20/2010EP1963277B1 Fluorinated compounds
01/20/2010EP1831159B1 Tetralin and indane derivatives and uses thereof
01/20/2010EP1513818B1 Heterocyclic inhibitors of vegfr-2 kinases
01/20/2010EP1202961B1 Arylsulfonamido-substituted hydroxamic acid derivatives
01/20/2010EP1077994B1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
01/20/2010CN101628896A Alkyl imidazoline quaternary ammonium salt, preparation method and application
01/20/2010CN100582084C Hydrophobic polyamine analogs and methods for their use
01/19/2010US7649098 (E)-1-(4-((1R,2S ,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)-ethanone oxime; inflammatory and autoimmune diseases
01/19/2010US7649015 Saquinavir-like, a Lopinavir-like, a Ritonavir-like, a Indinavir-lik, a atazanavir-like, Nelfinavir-like.a Tipranavir-like, a Amprenavir-like, a KNI-like. a cyclic carbonyl-like phosphonate HIV protease inhibitors; drug designing
01/19/2010US7649005 Substituted benzylaminoalkylene heterocycles
01/19/2010US7648999 Activator for peroxisome proliferator-activated receptor δ
01/19/2010CA2143135C Process for sulfinylating heterocyclic compounds
01/14/2010WO2010004228A2 Novel discriminating molecule family for neutron and gamma radiation
01/14/2010US20100010233 Process for preparing imidazolidin-2,4-dione compound and method for acquiring solid state 4,5-dihydroxy-2-imidazolidinone compound
01/14/2010US20100010217 Methods for the preparation of imidazole-containing compounds
01/14/2010US20100010049 Novel Tyrosinase inhibitors and pharmaceutical/cosmetic applications thereof
01/14/2010DE102008032595A1 Synthesis of ionic liquids, useful as liquid electrolyte in electrochemistry, comprises carrying out reaction of base material in continuous operating reactor, and carrying out addition of base material in continuous operating reactor
01/13/2010EP2143431A1 Protective agent for neurocyte comprising amidino derivative as active ingredient
01/13/2010EP2142515A1 Novel inhibitors
01/13/2010EP2142514A1 Thiourea derivatives as glutaminyl cyclase inhibitors
01/13/2010EP2142513A1 Nitrovinyl-diamine derivatives as glutaminyl cyclase inhibitors
01/13/2010EP2142512A2 Imidazolidine carboxamide derivatives as p2x7 modulators
01/13/2010EP2142507A1 Process for the preparation of sorafenib and salts thereof
01/13/2010EP2141990A1 11beta-hsd1 active compounds
01/13/2010EP1144388B1 Acyl derivatives which treat vla-4 related disorders
01/13/2010CN101627016A Chemical compounds
01/13/2010CN101624375A Ornidazole new crystal formation and preparation method thereof
01/13/2010CN101624374A Phenylnaphthylimidazoles for use on copper surfaces during soldering
01/13/2010CN100579967C Preparation and purification method for optical enantiomer of ornidaxole
01/13/2010CN100579966C Method for manufacturing imidazole compounds and salts and pseudopolymorphs thereof
01/12/2010US7645903 immunoglobulins; affinity chromatography
01/12/2010US7645805 a core which is functionalized with three amino acid derived groups by means of an amide or urea linkage. It may be used to gelate or thicken numerous solvents
01/12/2010US7645799 thromboembolic and/or inflammatory disorders; 4-Aminomethyl-cyclohexanecarboxylic acid (1-biphenyl-3-yl-2-phenyl-ethyl)-amide; selective inhibitors of serine protease enzymes of the coagulation cascade and/or contact activation system; improved pharmacological properties, plasma kallikrein activity
01/12/2010US7645797 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal
01/12/2010US7645760 1-(4-Benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
01/12/2010US7645757 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors
01/12/2010US7645434 Ionic liquid intermediates by reacting an alkali metal tetrafluoroborate with analkali metal cyanide in a solid state reaction; reacting preferably the potassium salt with an ammonium salt of pyridinium, imidazolium; chemical resistance; low viscosity; waterproofing; storage stability
01/12/2010CA2407463C N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
01/12/2010CA2192089C Inhibitors of interleukin-1.beta. converting enzyme
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 345